Literature DB >> 14555616

A functional genomics approach for the identification of putative tumor suppressor genes: Dickkopf-1 as suppressor of HeLa cell transformation.

Andrei M Mikheev1, Svetlana A Mikheeva, Binrong Liu, Pinchas Cohen, Helmut Zarbl.   

Abstract

We described previously the isolation and characterization of two non-tumorigenic revertants from the HeLa cervical carcinoma cell line, and demonstrated that loss of the transformed phenotype in these cells was the result of dominant somatic mutations. The goal of the present study was to use cDNA microarrays to identify candidate tumor suppressors among the set of genes whose increased expression correlated with loss of tumorigenicity in both revertants. Among the genes with significantly increased expression levels in both HA and HF revertants we identified Insulin Growth Factor Binding Protein-3 (IGFBP-3) and the Dickkopf-1 (DKK-1) genes. Both of these genes encode secreted proteins implicated in the modulation cell growth and differentiation, and IGFBP-3 was shown previously to have tumor suppressing activity. To test the hypothesis that increased expression of IGFBP-3 or the DKK-1 genes could have contributed to the suppression of tumorigenicity in the revertants, we expressed IGFBP-3 or DKK-1 in HeLa cells, and assessed their effects on anchorage dependent and independent growth, and tumor formation in athymic nude mice. Ectopic expression of IGFBP-3 or DKK-1 resulted in significantly decreased growth in soft agar. HeLa cells expressing ectopic IGFBP-3 or DKK-1 showed statistically significant differences in the kinetics of tumor formation. In any tumors that arose in animals injected with the IGFBP-3 expressing cells, there was a complete loss of IGFBP-3 activity, as measured by binding to IGF-1 and IGF-2 proteins. All tumors that arose after injection of cells expressing DKK-1, invariably showed almost a complete loss of ectopic DKK-1 expression. The observations that loss of DKK-1 expression or IGFBP-3 activity was required for tumorigenicity suggested that both proteins encode putative tumor suppressor genes. We also show that while DKK-1 expression does not affect cell growth in vitro, the protein does sensitize cells to apoptosis. We also demonstrated that effect of DKK-1 was not due to inhibition of beta-catenin/TCF4-regulated transcription. Taken together, our results indicate that somatic cell genetics combining with gene expression profiling may be a useful approach for the identification of functional suppressors of malignant cell growth.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14555616     DOI: 10.1093/carcin/bgg190

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  32 in total

1.  A transgenic, mesodermal specific, Dkk1 mouse model recapitulates a spectrum of human congenital limb reduction defects.

Authors:  Filemon Dela Cruz; Melissa Terry; Igor Matushansky
Journal:  Differentiation       Date:  2012-03-08       Impact factor: 3.880

Review 2.  Dickkopf1: a tumor suppressor or metastasis promoter?

Authors:  Mitchell E Menezes; Daniel J Devine; Lalita A Shevde; Rajeev S Samant
Journal:  Int J Cancer       Date:  2011-11-02       Impact factor: 7.396

Review 3.  Dickkopf1: An immunomodulatory ligand and Wnt antagonist in pathological inflammation.

Authors:  Wook-Jin Chae; Alfred L M Bothwell
Journal:  Differentiation       Date:  2019-06-12       Impact factor: 3.880

4.  The oxidative stress response regulates DKK1 expression through the JNK signaling cascade in multiple myeloma plasma cells.

Authors:  Simona Colla; Fenghuang Zhan; Wei Xiong; Xiaosong Wu; Hongwei Xu; Owen Stephens; Shmuel Yaccoby; Joshua Epstein; Bart Barlogie; John D Shaughnessy
Journal:  Blood       Date:  2007-01-25       Impact factor: 22.113

5.  DKK1 antagonizes Wnt signaling without promotion of LRP6 internalization and degradation.

Authors:  Mikhail V Semënov; Xinjun Zhang; Xi He
Journal:  J Biol Chem       Date:  2008-05-27       Impact factor: 5.157

6.  The expression of Wnt-inhibitor DKK1 (Dickkopf 1) is determined by intercellular crosstalk and hypoxia in human malignant gliomas.

Authors:  Ke-Tai Guo; Peng Fu; Kathrin Juerchott; Helena Motaln; Joachim Selbig; Tamara Lah; Jörg-Christian Tonn; Christian Schichor
Journal:  J Cancer Res Clin Oncol       Date:  2014-04-27       Impact factor: 4.553

7.  Vascular Endothelial Growth Factor Receptor-1 Is Synthetic Lethal to Aberrant {beta}-Catenin Activation in Colon Cancer.

Authors:  Snehal Naik; Robin S Dothager; Jayne Marasa; Cory L Lewis; David Piwnica-Worms
Journal:  Clin Cancer Res       Date:  2009-12-15       Impact factor: 12.531

8.  Dickkopf-1 promotes hyperglycemia-induced accumulation of mesangial matrix and renal dysfunction.

Authors:  Chun-Liang Lin; Jeng-Yi Wang; Jih-Yang Ko; Yu-Ting Huang; Yu-Hsia Kuo; Feng-Sheng Wang
Journal:  J Am Soc Nephrol       Date:  2009-12-17       Impact factor: 10.121

9.  Olig2-induced neural stem cell differentiation involves downregulation of Wnt signaling and induction of Dickkopf-1 expression.

Authors:  Sung-Min Ahn; Kyunghee Byun; Deokhoon Kim; Kiyoung Lee; Jong Shin Yoo; Seung U Kim; Eek-Hoon Jho; Richard J Simpson; Bonghee Lee
Journal:  PLoS One       Date:  2008-12-18       Impact factor: 3.240

10.  Analysis of the expression profile of Dickkopf-1 gene in human glioma and the association with tumor malignancy.

Authors:  Youxin Zhou; Fang Liu; Qinian Xu; Xiuyun Wang
Journal:  J Exp Clin Cancer Res       Date:  2010-10-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.